Noncovalent BTK Inhibitors in CLL
Recommendations for applying information from clinical trials presented at oncology and hematology conferences in 2021 into routine clinical practice when managing patients with chronic lymphocytic leukemia.
Read More
Dr. Barrientos on Advances in the Treatment Landscape for Patients With CLL
August 8th 2018Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses advances in the treatment landscape for patients with chronic lymphocytic leukemia (CLL).
Read More